Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.69p
   
  • Change Today:
      0.090p
  • 52 Week High: 17.60p
  • 52 Week Low: 3.33p
  • Currency: UK Pounds
  • Shares Issued: 623.91m
  • Volume: 52,111
  • Market Cap: £23.02m
  • RiskGrade: 328
  • Beta: 0.01

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £54,924
Lisa Baderoon 583,963 £21,548
Tim Franklin 525,000 £19,372

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 91,523,156 £3,377,204
Invesco Ltd 17,872,341 £659,489
Aviva Investors Global 11,285,180 £416,423
Alora Pharmaceuticals LLC 10,909,091 £402,546
M&G Investments 7,600,000 £280,440
Prudential plc 7,600,000 £280,440
Capital Income Builder 4,870,367 £179,716
Dr R Zimmer 4,551,553 £167,952
Odey Asset Management 3,433,319 £126,690
Rhone Trustees (Switzerland) SA 3,386,000 £124,943
Pictet Overseas Trust Corporation Limited 3,287,500 £121,309

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 3.69p
Change Today 0.090p
% Change 2.50 %
52 Week High 17.60p
52 Week Low 3.33p
Volume 52,111
Shares Issued 623.91m
Market Cap £23.02m
Beta 0.01
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 14-Sep-2026

Time Volume / Share Price
09:43 21,488 @ 3.80p
09:36 7,000 @ 3.54p
09:23 10,000 @ 3.53p
08:35 24 @ 4.10p
08:35 35 @ 4.10p

Immupharma Key Personnel

CFO Ashley Clarke

Top of Page